Please login to the form below

Not currently logged in


This page shows the latest CVnCoV news and features for those working in and with pharma, biotech and healthcare.

CureVac to push ahead with first- and second-generation COVID-19 vaccines

CureVac to push ahead with first- and second-generation COVID-19 vaccines

CVnCoV offered 77% protection against moderate to severe disease and 100% protection against hospitalisation or death in people aged between 18 and 60. ... The candidate features a new, optimised mRNA backbone that causes “earlier and stronger immune

Latest news

More from news
Approximately 7 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...